Total Payments
$37,104
2024 Payments
$11,272
Companies
18
Transactions
113
Medicare Patients
4,528
Medicare Billing
$2.1M
Payment Breakdown by Category
Consulting$18,668 (50.3%)
Other$9,755 (26.3%)
Food & Beverage$4,965 (13.4%)
Travel$3,716 (10.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,668 | 7 | 50.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,405 | 2 | 17.3% |
| Food and Beverage | $4,965 | 91 | 13.4% |
| Travel and Lodging | $3,716 | 10 | 10.0% |
| Honoraria | $3,350 | 3 | 9.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | $16,250 | 24 | $0 (2024) |
| Genentech USA, Inc. | $7,698 | 28 | $0 (2024) |
| Topcon Healthcare, Inc. | $5,058 | 3 | $0 (2024) |
| F. Hoffmann-La Roche AG | $2,892 | 2 | $0 (2024) |
| Alimera Sciences, Inc. | $2,798 | 18 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $1,063 | 3 | $0 (2022) |
| Alcon Vision LLC | $339.15 | 7 | $0 (2022) |
| Alcon Laboratories Inc | $203.38 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $193.93 | 4 | $0 (2024) |
| Biogen, Inc. | $126.19 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,272 | 32 | Topcon Healthcare, Inc. ($5,058) |
| 2023 | $22,385 | 42 | Apellis Pharmaceuticals, Inc. ($14,399) |
| 2022 | $2,349 | 23 | EyePoint Pharmaceuticals US, Inc. ($900.00) |
| 2021 | $294.58 | 4 | EyePoint Pharmaceuticals US, Inc. ($162.64) |
| 2020 | $125.69 | 2 | Novartis Pharmaceuticals Corporation ($109.79) |
| 2019 | $474.50 | 8 | Alcon Vision LLC ($324.96) |
| 2018 | $203.38 | 2 | Alcon Laboratories Inc ($203.38) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $705.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/20/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Topcon Healthcare, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 12/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.31 | General |
| 12/04/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $58.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/27/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/30/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/22/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/02/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: EYE CARE | ||||||
| 07/29/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.26 | General |
| 07/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/21/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $145.69 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Ophthalmology | ||||||
| 07/19/2024 | F. Hoffmann-La Roche AG | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/19/2024 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $92.16 | General |
| 07/19/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.81 | General |
| 07/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $117.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $148.51 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/08/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $121.11 | General |
| 05/08/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $66.82 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,855 | 16,077 | $5.4M | $1.5M |
| 2022 | 19 | 1,282 | 2,315 | $1.6M | $461,760 |
| 2021 | 8 | 236 | 268 | $236,023 | $45,590 |
| 2020 | 6 | 155 | 196 | $142,861 | $49,301 |
Total Patients
4,528
Total Services
18,856
Medicare Billing
$2.1M
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 139 | 1,148 | $2.1M | $793,625 | 37.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 42 | 9,062 | $1.1M | $262,994 | 24.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 45 | 812 | $649,600 | $145,633 | 22.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 278 | 1,044 | $730,800 | $91,684 | 12.5% |
| 92134 | Imaging of retina | Office | 2023 | 531 | 1,601 | $160,100 | $42,642 | 26.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 246 | 291 | $58,200 | $28,723 | 49.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 236 | 308 | $69,300 | $28,714 | 41.4% |
| J3590 | Unclassified biologics | Office | 2023 | 103 | 310 | $77,500 | $21,147 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 189 | 189 | $47,250 | $20,851 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 184 | $36,800 | $16,302 | 44.3% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 16 | 16 | $57,600 | $14,024 | 24.3% |
| 92250 | Photography of the retina | Office | 2023 | 430 | 549 | $68,625 | $13,339 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 173 | 233 | $30,290 | $12,798 | 42.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 14 | 14 | $42,000 | $11,843 | 28.2% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 44 | 48 | $90,000 | $8,628 | 9.6% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 12 | 13 | $39,000 | $8,419 | 21.6% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 18 | 30 | $33,000 | $7,720 | 23.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 66 | 66 | $13,200 | $7,131 | 54.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $6,880 | $2,582 | 37.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 24 | 32 | $8,000 | $1,780 | 22.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 24 | 30 | $6,760 | $1,050 | 15.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 13 | 13 | $1,950 | $812.76 | 41.7% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2023 | 15 | 16 | $3,825 | $623.35 | 16.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 15 | 25 | $1,875 | $441.84 | 23.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 89 | 370 | $707,660 | $263,037 | 37.2% |
About Michael Ellis
Michael Ellis is a Ophthalmology healthcare provider based in Lenexa, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1598127243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Ellis has received a total of $37,104 in payments from pharmaceutical and medical device companies, with $11,272 received in 2024. These payments were reported across 113 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($18,668).
As a Medicare-enrolled provider, Ellis has provided services to 4,528 Medicare beneficiaries, totaling 18,856 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Lenexa, KS
- Active Since 03/22/2016
- Last Updated 09/06/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598127243
Products in Payments
- Syfovre (Drug) $8,996
- Vabysmo (Drug) $8,425
- ILUVIEN (Drug) $2,581
- Susvimo (Drug) $1,410
- YUTIQ (Drug) $1,264
- VABYSMO (Drug) $310.27
- Centurion (Device) $281.43
- EYLEA (Biological) $193.93
- PanOptix (Device) $137.93
- Lucentis (Biological) $126.93
- BEOVU (Drug) $109.79
- AcrySof (Device) $108.98
- OZURDEX (Drug) $100.12
- Izervay (Drug) $53.28
- PURIFIED CORTROPHIN GEL (Drug) $51.93
- LUMIGAN (Drug) $46.28
- XIPERE (Drug) $42.86
- SUSVIMO (Drug) $37.50
- Cimerli (Biological) $34.89
- Rhopressa (Drug) $22.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lenexa
Dr. Daniel Feiler, M.d, M.D
Ophthalmology — Payments: $30,509
Ophthalmology $30,509
Dr. Ivan Batlle, Md, MD
Ophthalmology — Payments: $9,083
Ophthalmology $9,083
Dr. David Dyer, M.d, M.D
Ophthalmology — Payments: $8,164
Ophthalmology $8,164
Dr. Neeti Alapati, Md, MD
Ophthalmology — Payments: $3,894
Ophthalmology $3,894
Dr. Gregory Fox, M.d, M.D
Ophthalmology — Payments: $3,642
Ophthalmology $3,642
Dr. Steven Cohen, M.d, M.D
Ophthalmology — Payments: $3,166
Ophthalmology $3,166